- Fact Sheet
- Summary Prospectus
- Regular Application
- Annual Report
- Semi-Annual Report
- IRA Application
- Coverdell Application
- IRA Transfer Form
- IRA Distribution Form
- Statement of Additional Information
- Report in XBRL format IRA Disclosure
Before you invest in the Convergence Core Plus Fund, please refer to the Summary Prospectus and Prospectus for important information about the investment company, including investment objectives, risks, charges and expenses. You may also obtain a hardcopy of the statutory prospectus and summary prospectus by calling 1-877-677-9414. The prospectus should be read carefully before you invest or send money.
The Fund is offered only to United States residents, and information on this site is intended only for such persons. Nothing on this web site should be considered a solicitation to buy or an offer to sell shares of the Fund in any jurisdiction where the offer or solicitation would be unlawful under the securities laws of such jurisdiction.
Mutual fund investing involves risk. Principal loss is possible. Investments in midcap companies involve additional risk such as limited liquidity and greater volatility than larger capitalization companies. The Fund invests in foreign securities which involve greater volatility and political, economic and currency risks and differences in accounting methods. The fund regularly makes short sales of securities, which involves unlimited risk including the possibility that losses may exceed the original amount invested. However, a mutual fund investor’s risk is limited to one’s amount of investment in a mutual fund.
Alpha is an annualized return measure of how much better or worse a fund’s performance is relative to an index of funds in the same category, after allowing for differences in risk. You cannot invest directly in an index.
Convergence Investment Partners is the advisor to the Convergence Core Plus Fund, which is distributed by Quasar Distributors, LLC.
Convergence Investment Partners is majority owned by Montage Investments LLC